NRX Pharmaceuticals, Inc.
NRXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001719406
No open-market purchases or sales by NRX Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $47.6M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding NRX Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 30 | 33 | +3 |
| Shares | 4.12M | 3.10M | −1.02M (−24.8%) |
| Value | $3.04M | $3.44M | +$392.2K (+12.9%) |
New holders (10)
Institutions that held NRX Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HBK Sorce Advisory LLC | 58,460 | $65.0K | 0.00% |
| Charles Schwab Investment Management Inc | 43,732 | $48.5K | 0.00% |
| AE Wealth Management LLC | 29,515 | $32.8K | 0.00% |
| HRT Financial LP | 26,501 | $29.0K | 0.00% |
| Jenkins Wealth | 14,176 | $15.7K | 0.01% |
| Citadel Advisors LLC | 12,556 | $13.9K | 0.00% |
| Two Sigma Securities, LLC | 10,453 | $11.6K | 0.00% |
| UBS Group AG | 390 | $433 | 0.00% |
| Column Capital Advisors, LLC | 100 | $111 | 0.00% |
| GWM Advisors LLC | 825 | $1 | 0.00% |
Sold out (7)
Institutions that held NRX Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Owl Creek Asset Management, L.P. | 50,000 | $37.0K |
| Goldman Sachs Group Inc | 21,619 | $16.0K |
| Simplex Trading, LLC | 14,225 | $10.0K |
| Davenport & Co LLC | 10,000 | $7.00K |
| Citigroup Inc | 8,759 | $6.00K |
| Daiwa Securities Group Inc. | 172 | $0 |
| China Universal Asset Management Co., Ltd. | 633 | $0 |